Aura Biosciences, Inc. is a biopharmaceutical company known for using its technology to design novel therapies. It operates in the field of oncology, primarily developing drug products that target and destroy cancer cells.
Within the healthcare and biotechnology sector, Aura has a mission to revolutionise clinical-stage cancer treatment. Its main service revolves around developing new biopharmaceutical products and novel therapies in the oncology field. Aura’s work is supported by a number of partnerships within the biopharmaceutical industry.
Monitor the AURA share price by adding it to your eToro watchlist.